Blackburn David F, Wilson Thomas W
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon.
Can J Cardiol. 2006 Mar 1;22(3):229-33. doi: 10.1016/s0828-282x(06)70902-3.
Increased rates of diabetes have been reported with thiazide diuretics and beta-blockers, but not with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or calcium channel blockers. These observations are important because significant glycemic effects of drugs may be a source of accelerated cardiovascular risk that is not detectable during restricted clinical trial follow-up periods. The extent to which diabetes is affected by these medications remains unclear, as is the precise mechanism by which diabetes is promoted. However, several plausible theories are presented herein. Although drug-induced diabetes has been a concern for several years, not enough information is available to influence prescribing for the majority of patients. The number one priority should be controlling blood pressure in a timely manner.
噻嗪类利尿剂和β受体阻滞剂与糖尿病发病率增加有关,但血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂或钙通道阻滞剂则不然。这些观察结果很重要,因为药物显著的血糖效应可能是心血管风险加速的一个来源,而在有限的临床试验随访期内无法检测到。这些药物对糖尿病的影响程度尚不清楚,糖尿病的促发机制也不明确。然而,本文提出了几种合理的理论。尽管药物性糖尿病多年来一直受到关注,但没有足够的信息来影响大多数患者的用药处方。首要任务应该是及时控制血压。